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Background: The purpose of this study was to assess the relationship of smoking duration
with respiratory symptoms and history of chronic obstructive pulmonary disease (COPD) in
the South Carolina Behavioral Risk Factor Surveillance System survey in 2012.
Methods: Data from 4,135 adults aged $45 years with a smoking history were analyzed using
multivariable logistic regression that accounted for sex, age, race/ethnicity, education, and current smoking status, as well as the complex sampling design.
Results: The distribution of smoking duration ranged from 19.2% (1–9 years) to 36.2%
($30 years). Among 1,454 respondents who had smoked for $30 years, 58.3% were current smokers, 25.0% had frequent productive cough, 11.2% had frequent shortness of breath,
16.7% strongly agreed that shortness of breath affected physical activity, and 25.6% had been
diagnosed with COPD. Prevalence of COPD and each respiratory symptom was lower among
former smokers who quit $10 years earlier compared with current smokers. Smoking duration
had a linear relationship with COPD (P,0.001) and all three respiratory symptoms (P,0.001)
after adjusting for smoking status and other covariates. While COPD prevalence increased
with prolonged smoking duration in both men and women, women had a higher age-adjusted
prevalence of COPD in the 1–9 years, 20–29 years, and $30 years duration periods.
Conclusion: These state population data confirm that prolonged tobacco use is associated with
respiratory symptoms and COPD after controlling for current smoking behavior.
Keywords: tobacco use, chronic obstructive pulmonary disease, respiratory symptoms,
population-based study

Introduction
Chronic obstructive pulmonary disease (COPD), which includes both chronic bronchitis
and emphysema, is characterized by airflow obstruction, and may be accompanied
by airway hyperreactivity, chronic cough, sputum production, shortness of breath
(SOB), wheezing, exercise intolerance, and poor quality of life.1,2 For 50 years, the
biologic plausibility for a link between cigarette smoking and adverse respiratory
system outcomes has been supported by epidemiologic and clinical evidence. 3,4
Risks of lung cancer, COPD, and other respiratory conditions such as asthma are
increased in smokers, particularly among those with extensive exposure histories.4
Sex also appears to affect the risk of adverse respiratory effects from smoking.
Most studies show that smoking has greater adverse effects on respiratory function
among women than among men.5–11 However, other studies have not been consistent
with that finding.12–15 The sex difference in many previous studies of international
populations or small study populations was observed when using self-reported
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pack-years (product of intensity and duration) of smoking
as a measure of tobacco exposure.6–8,11–13,15
There has been little information about the relationship between respiratory symptoms and number of years
(duration) of tobacco use, particularly in a population representative of a US state. This is also true with regard to the
relationship between duration of tobacco use, respiratory
symptoms, and sex. Pack-year history requires the use of
two survey questions, whereas years of tobacco use can be
estimated by a single question. South Carolina is a US state
with a high prevalence of current smoking (21.0% in 2010)
and COPD (7.7% in 2011), and a high mortality rate from
COPD (68.6 per 100,000 in 2010).16,17 The South Carolina
Behavioral Risk Factor Surveillance System (BRFSS), an
annual health survey, included state-added questions regarding years of tobacco use and respiratory symptoms in 2012
and provided an opportunity to assess the association of
prolonged tobacco use with respiratory symptoms and COPD
in a contemporary state population of adult respondents with
a smoking history.

Materials and methods
The BRFSS is an annual random-digital-dialed telephone
survey conducted by state health departments in collaboration with the Centers for Disease Control and Prevention
(CDC) in all 50 states, the District of Columbia, and US
territories. The state-based BRFSS has collected data from
households with landline and cellular telephones, and has
incorporated a new sample weighting method since 2011
(http://www.cdc.gov/brfss/annual_data/annual_2011.
htm). The BRFSS includes core questions about sociodemographic characteristics, risk behaviors, and chronic
diseases including COPD; optional modules (standardized
questions provided by the CDC and chosen by a state based
on the state’s priorities and budget); and questions added
by the state. Questions addressing respiratory symptoms
and years of tobacco use were added to the 2012 South
Carolina BRFSS and were analyzed in this study. The
2012 South Carolina BRFSS combined response rate (the
number of respondents who completed the survey as a
proportion of all eligible and likely eligible persons using
standards set by the American Association of Public Opinion Research Response Rate Formula #4 [http://www.aapor.
org/Standard_Definitions2.htm]) was 48.6% (http://www.
cdc.gov/brfss/annual_data/2012/pdf/SummaryDataQuality
Report2012_20130712.pdf). This study is a secondary data
analysis, which is exempt from the need for approval of an
institutional review board.
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Respiratory outcomes
A history of COPD was defined by the subject’s affirmative
responses to the question “Has a doctor, nurse, or other health
professional ever told you that you have chronic obstructive pulmonary disease or COPD, emphysema or chronic
bronchitis?” The small number of persons who reported
“don’t know/not sure” were defined as not having been
diagnosed with COPD. Overall, 76.4% of respondents with
self-reported COPD also reported having had a breathing
test such as spirometry.
Respiratory symptoms were measured by three variables.
In response to the question “How often do you cough up
mucus or phlegm?”, we defined the presence of a frequent
phlegm-producing cough as a response of “everyday”, or
“most days a week” to compare with respondents with “a few
days a month”, “only with occasional colds or chest infections”, or “never”. In response to “During the past 30 days,
how often did you feel short of breath?”, we defined frequent
SOB as a response of “all the time” or “most of the time” to
compare with respondents with a response of “some of the
time”, “a little of the time”, or “none of the time”. For the
third question “Thinking about your physical activity during the last 12 months, do you agree slightly or strongly, or
disagree slightly or strongly with the following statement:
I do less now than I used to because of my breathing problems”, we compared those who said “strongly agree” with
respondents who gave the other response options. These
three respiratory symptom questions were selected from a
validated study with a positive predictive value of 56.8% and
a negative predictive value of 86.4%, which is considered
to be a highly reliable questionnaire when compared with
spirometry measures.18

Smoking behaviors
For the analyses presented in this report, we identified respondents with a history of cigarette smoking by an affirmative
response to the tobacco use question, “Have you smoked
at least 100 cigarettes in your entire life?” Years (duration)
of tobacco use were further determined from the question
“Over your lifetime, how many years have you smoked
tobacco products?” and were divided into four duration
groups (1–9 years, 10–19 years, 20–29 years, and $30 years).
Persons who responded “not at all” to the third tobacco use
question, “Do you now smoke cigarettes, every day, some
days, or not at all?” were defined as former smokers and the
remainder were defined as current smokers. Former smokers were also asked to identify how long it had been since
they last smoked a cigarette, even one or two puffs. Former
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smokers were then defined either by having quit smoking
for $10 years (72.7%) or by all other responses (26.8%
reported quit durations ,10 years and 0.5% failed to provide
information on quit duration).
We restricted this study to adults aged $45 years because
there was a low prevalence of COPD (3.7%) and smoking $30 years (1.9%) among respondents aged 18–44 years,
resulting in unstable sample sizes in that age group. In the
survey population of 9,386 respondents aged $45 years,
46.2% had never smoked, 33.8% were former smokers, and
18.3% were current smokers. Leffondre et al has observed
that inclusion of respondents who have never smoked may
produce overestimations of the effects of smoking duration
when that group is assigned a value of zero smoking years
and is set as the referent group in an analysis;19 therefore,
we restricted this study to former and current smokers
(4,553 respondents) aged $45 years. Data from 4,135
(90.8%) respondents who provided information on smoking
duration, respiratory symptoms, and history of COPD were
analyzed in this study after those who had missing information were excluded.

Statistical analysis
We examined the distributions of selected characteristics
among study respondents by smoking duration. We estimated
95% confidence intervals (CIs) for the percentages and used
two-sided t-tests to compare characteristics between groups
defined by smoking duration and to assess linear trends in
characteristics by smoking duration. The distribution of
smoking duration by current smoking status (current smokers,
former smokers who had quit for $10 years, and other former
smokers) was also examined. The age-adjusted prevalence
and 95% CI of respiratory symptoms and COPD by smoking
duration and current smoking status were obtained from separate logistic regression models that included age (45–59 years,
60–69 years, and $70 years) as the covariate. Finally, we
assessed the adjusted prevalence ratios and 95% CIs for
the likelihood of having respiratory symptoms and COPD
associated with smoking duration using separate multivariable logistic regression models that included sex, age, race/
ethnicity (non-Hispanic white, non-Hispanic black, or other/
multiracial), education (less than a high school diploma, a
high school graduate or equivalent, or at least some college),
and current smoking status (current vs former) as covariates. Prior research suggesting that women might be more
susceptible than men to the effects of smoking prompted
testing for an interaction between sex and smoking duration
in separate age-adjusted logistic regression models for each
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of the four dependent variables. The only sex interaction was
observed for COPD (P=0.085). We also assessed whether the
relationships between smoking duration and the dependent
variables differed by current smoking status, but failed to
find a significant interaction for COPD (P=0.79) or for any
of the three respiratory symptoms (P.0.42). There were also
no significant interactions between age and sleep duration
for any outcome (P.0.30). All analyses were conducted
using Statistical Analysis System (SAS)-callable SUDAAN
(Release 10.0.1, Research Triangle Institute, NC, USA) to
account for the complex sampling design.

Results
Table 1 shows the distribution of selected characteristics
by smoking duration among 4,135 adults aged $45 years
with a history of smoking. The distributions of age and race/
ethnicity did not differ significantly by smoking duration.
Respondents who had smoked for $30 years were more
likely to be male (P,0.05), have less than a high school
education (P,0.05), and less likely to have some college
education (P,0.05) than persons who had smoked for 1–9
years or 10–19 years. The proportion of the study population
who were current smokers increased with increasing smoking
duration (linear trend, P,0.05) such that 58.3% of those who
had smoked for $30 years continued to be current smokers
compared with 7.5% of those who had smoked for 1–9 years.
The proportion of the study population comprising former
smokers with quit durations of $10 years declined as smoking duration increased (linear trend, P,0.05).
The distribution of smoking duration was 19.2%
for 1–9 years, 21.6% for 10–19 years, 23.0% for 20–29 years,
and 36.2% for $30 years. The increase in the proportions for
each smoking duration was observed in men and women, all
age groups, non-Hispanic whites, non-Hispanic blacks, and
all education groups (data not shown). Figure 1 shows an
inverse linear trend for smoking duration category in former
smokers with quit durations of $10 years, while current
smokers and other former smokers had a linear increase such
that 60.0% of all current smokers and 43.6% of other former
smokers had smoked for $30 years in contrast with 15.6%
of former smokers who had quit for $10 years.
We assessed the age-adjusted prevalence of COPD and
the three respiratory symptoms by current smoking status
(Figure 2). Former smokers with quit durations $10 years
reported a significantly lower age-adjusted percentage of
frequent productive cough (10.6% vs 24.2%, respectively,
P,0.001), frequent SOB (5.7% vs 9.9%, P=0.001), agreement that SOB affects physical activity (8.8% vs 13.8%,
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Table 1 Distribution of selected characteristics among 4,135 adults aged $45 years with a smoking history by smoking duration in
South Carolina, 2012 (Behavioral Risk Factor Surveillance System)
Characteristic

na

Sex
Men
Women
Age (years)
45–59
60–69
70
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Other/multiracial
Education
Less than high school diploma
High school graduate or equivalent
At least some college
Smoking status
Current smokers
Former smokers (quit $10 years)
Other former smokersd

Smoking duration (years)
1–9
(n=799)
% (95% CI)b

10–19
(n=952)
% (95% CI)b

20–29
(n=930)
% (95% CI)b

$30
(n=1,454)
% (95% CI)b

1,971
2,164

46.4 (41.3–51.6)
53.6 (48.4–58.7)

49.4 (44.8–54.0)
50.6 (46.0–55.2)

59.3 (54.9–63.5)
40.7 (36.5–45.1)

59.2 (55.7–62.7)
40.8 (37.3–44.3)

1,555
1,371
1,209

49.6 (44.5–54.7)
33.4 (28.8–38.4)
17.0 (13.9–20.5)

51.3 (46.7–55.8)
26.1 (22.5–30.1)
22.6 (19.3–26.3)

52.1 (47.6–56.7)
25.9 (22.3–29.8)
22.0 (18.7–25.7)

47.2 (43.5–50.9)
30.7 (27.4–34.1)
22.1 (19.6–24.9)

3,092
862
181

73.5 (68.5–78.0)
22.3 (18.3–27.0)
–c

73.7 (69.3–77.7)
21.7 (18.0–25.8)
–c

76.0 (71.6–79.9)
19.1 (15.7–23.1)
–c

79.5 (76.2–82.5)
15.4 (12.8–18.3)
5.1 (3.5– 7.4)

580
1,297
2,258

14.9 (11.1–19.8)
26.4 (22.1–31.2)
58.7 (53.4–63.8)

14.1 (10.9–18.0)
32.6 (28.4–37.0)
53.4 (48.7–57.9)

20.6 (16.7–25.2)
36.3 (32.0–40.8)
43.1 (38.8–47.6)

26.6 (23.1–30.3)
32.1 (28.9–35.5)
41.3 (37.9–44.9)

1,253
2,157
722

7.5 (5.1–10.8)
79.8 (75.4–83.6)
12.7 (9.8–16.4)

20.6 (16.9–25.0)
65.0 (60.3–69.4)
14.4 (11.3–18.1)

35.3 (30.8–40.0)
45.5 (41.0–50.0)
19.2 (15.8–23.1)

58.3 (54.7–61.8)
20.4 (17.8–23.3)
21.3 (18.5–24.5)

Notes: aUnweighted sample size; bweighted percentage and 95% CI; cunreliable estimate due to small sample size; dother former smokers include persons who did not
provide quit durations (n=11) as well as those with quit durations ,10 years.
Abbreviation: CI, confidence interval.



&XUUHQWVPRNHUV
2WKHUIRUPHUVPRNHUV
)RUPHUVPRNHUV \HDUV

3HUFHQWDJH



Data in Table 2 demonstrate that the age-adjusted prevalence of each respiratory symptom and COPD increased with
increasing smoking duration (linear trend, P,0.001). Among
those who had smoked for $30 years, 25.6% reported COPD,
25.0% had frequent productive cough, 11.2% had frequent
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P,0.0001), and COPD (8.6% vs 22.7%, P,0.0001)
compared with current smokers. In contrast, other former
smokers with either no stated quit duration or quit durations
,10 years did not differ significantly from current smokers
in prevalence of frequent SOB, agreement that SOB affects
physical activity, and COPD, although this former smoker
group reported a significant lower age-adjusted percentage of
frequent productive cough than did current smokers (11.5%
vs 24.2%, P,0.0001).
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Figure 1 Distribution of years of tobacco exposure among 4,135 adults aged
$45 years with a smoking history by current smoking status in South Carolina, 2012
(Behavioral Risk Factor Surveillance System).
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Figure 2 Age-adjusted percentage of respiratory symptoms and COPD among
adults aged 45 years with a smoking history by current smoking status in South
Carolina, 2012 (Behavioral Risk Factor Surveillance System).
Abbreviations: COPD, chronic obstructive pulmonary disease; SOB, shortness
of breath.
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Notes: aUnweighted sample size; bweighted age-adjusted prevalence; cPR and 95% (CI) for the likelihood of having each dependent variable associated with selected years compared with 1–9 years of smoking were obtained from separate
multivariable logistic regression models that included sex, age, race/ethnicity, education, and current smoking status (current vs former) as covariates.
Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; SOB, shortness of breath; PR, prevalence ratio.

0.009
0.51
0.57
1.85 (1.06–3.21)
1.37 (0.59–3.17)
1.41 (0.74–2.67)
Adults without COPD (n=3,495)a
Frequent productive cough
Frequent SOB
Strongly agree SOB affects physical activity

a

Study population (n=4,135)
COPD
Frequent productive cough
Frequent SOB
Strongly agree SOB affects physical activity

799
6.8
7.0
3.7
6.4
738
5.8
2.2
4.8

1.00 (referent)
1.00 (referent)
1.00 (referent)

1.00 (referent)
1.00 (referent)
1.00 (referent)
1.00 (referent)

952
9.1
9.2
5.5
9.6
871
6.5
3.4
6.3

1.01 (0.55–1.85)
1.48 (0.60–3.64)
1.38 (0.72–2.61)

1.32 (0.87–2.02)
1.20 (0.73–1.97)
1.54 (0.81–2.95)
1.58 (0.97–2.58)

930
11.6
14.7
7.7
12.3
811
12.0
4.8
7.9

1.55 (0.87–2.74)
1.90 (0.80–4.50)
1.57 (0.84–2.96)

1,454
25.6
25.0
11.2
16.7
1,075
16.5
3.7
6.9
1.64 (1.08–2.48)
1.67 (1.04–2.69)
2.04 (1.10–3.77)
1.94 (1.20–3.14)

%b
%b
%b
%b

PR (95% CI)c

10–19
1–9

Smoking duration (years)

PR (95% CI)c

20–29

PR (95% CI)c

$30

PR (95% CI)c

3.39 (2.32–4.96)
2.55 (1.63–3.98)
2.90 (1.64–5.15)
2.72 (1.71–4.31)

,0.001
,0.001
,0.001
,0.001

P-value
(linear trend)

Smoking duration and COPD

Characteristic

Table 2 Age-adjusted prevalence and multivariable-adjusted likelihood of COPD and selected respiratory symptoms associated with smoking duration among adults aged $45 years
with a history of smoking in South Carolina, 2012 (Behavioral Risk Factor Surveillance System)
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Figure 3 Age-adjusted prevalence of chronic obstructive pulmonary disease among
adults aged 45 years with a history of smoking by sex and smoking duration in
South Carolina, 2012 (Behavioral Risk Factor Surveillance System).

SOB, and 16.7% strongly agreed that SOB had affected
physical activity in the previous year. After controlling for
age, sex, race/ethnicity, education, and current smoking status, there remained an increased likelihood for having COPD
and all three respiratory symptoms associated with increasing
smoking duration (linear trend, P,0.001).
However, after restricting the analyses to the 3,495
respondents who responded that they had not been diagnosed
with COPD, only one respiratory symptom remained significantly associated with smoking duration (Table 2, P,0.001).
The age-adjusted percentage of respondents without COPD
who reported having frequent productive cough increased
with increasing smoking duration (linear trend, P,0.001).
This relationship persisted even after adjustment for age, sex,
race/ethnicity, education, and current smoking status (linear
trend, P=0.009). However, only a modest significant association was observed among respondents without COPD and
with a smoking duration $30 years compared with those in
the 1–9 year duration (prevalence ratio 1.85; 95% confidence
interval 1.06–3.21).
There was a borderline significant sex interaction
(P=0.085) of the relationship between smoking duration and
prevalence of COPD (Figure 3). The age-adjusted prevalence
increased with increasing smoking duration for both men
and women. However, women had a significantly higher
age-adjusted prevalence of COPD than men for a smoking
duration of 1–9 years (10.1% vs 2.8%, P,0.001), 20–29
years (15.3% vs 9.2%, P=0.04), and $30 years (30.9% vs
21.9%, P,0.001) but there was no difference at 10–19 years
(9.3% vs 8.9%, P=0.93).

Discussion
Our study is the first population-based health survey in
many years that has assessed the relationship between
duration of tobacco use and respiratory outcomes in adults
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with a smoking history in the USA. This study provides a
population-based perspective of the relationship between
smoking duration, three respiratory symptoms, and COPD
in a US state with a high prevalence of current cigarette
smoking and COPD. These relationships in a contemporary
population in 2012 are consistent with similar dose–response
relationships observed in a Norwegian study (1995–1997)
for number of pack-years of smoking and chronic bronchitis,
breathlessness, persistent coughing, coughing with phlegm,
and reduced lung function.7,8 We observed that the significant
relationship between smoking duration and frequent productive cough was also present in adults without a self-reported
diagnosis of COPD; however, the relationship between
smoking duration, frequent SOB, and the effects of SOB on
physical activity were not significant in adults without COPD.
Our results also showed that smoking cessation for $10 years
in contrast with current smoking was associated with a much
lower prevalence of COPD and of each of the three respiratory symptoms. Our results are consistent with the COPD
prevention strategy that smoking cessation improves respiratory function and prevents excessive decline in lung function
in smokers with COPD as well as in smokers without chronic
symptoms.20,21 The health benefits of smoking cessation with
regard to the rate of decline in forced expiratory volume in
1 second (FEV1) and mortality appear to be most significant
for persons who quit before 40–50 years of age.14,22
The sex difference in the age-adjusted relationship of
smoking duration with COPD demonstrated in this study is
consistent with reports that women may be more susceptible
to the detrimental effects of smoking at the 1–9 year duration than men. Women were similar to men in terms of the
significant relationship between smoking duration and respiratory symptoms. Prior studies conducted in the late 1990s and
early 2000s suggested that women smokers were particularly
susceptible to the deleterious effects of smoking, with an augmented decline in FEV1 compared with male smokers.6,8,9,11,20
In addition, results from the Lung Health Study (1986–1994)
showed that smoking cessation has a greater impact on rate of
FEV1 decline in women than in men.23 However, Kohansal et
al did not report a sex difference in the loss of lung function
associated with continued or stopping smoking.14 Suggested
explanations for the female–male difference in relationship
between smoking duration and respiratory function have
included sex variation in the prevalence of lifetime smoking,
biologic differences such as smaller lungs and larger airways
in women, hormonal factors that influence epithelial cell
function, sex differences in inflammatory responses, greater
awareness or recall of respiratory symptoms and diagnosed
disease among women, and sex differences in the clinical
1414
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presentation of COPD.8,20,24 A previous study suggested that
African-American women with COPD had a greater loss of
lung function due to cigarette smoking than other COPD
patients.5,25 However, the current study did not have a sample
size sufficient to assess that relationship in groups defined by
race, sex, and smoking duration.
As would be expected, current smokers were more likely
to have a frequent productive cough. The “smoker’s cough”
is consistent with chronic bronchitis, and is primarily due
to excessive inflammation and hypersecretion of mucus
secondary to smoking tobacco products.3,26 Analysis of the
COPDGene cohort showed that slightly more than one quarter of COPD subjects reported chronic bronchitis.27 There
was also a twofold increase in risk of chronic bronchitis in
current smokers in the COPDGene study. In contrast, more
than one-third of our study respondents reported a frequent
productive cough, perhaps reflecting causes of chronic cough
other than COPD. Notably, there was less of a difference in
the frequency of dyspnea between current vs former smokers; we speculate that dyspnea may be an important reason
for smoking cessation in some cases.
Chronic productive cough also increased with smoking
duration among smokers with no evidence of COPD in the
current study. A study that evaluated the relationship among
respiratory symptoms, COPD, and airflow for over 30 years
found that 40% of smokers developed chronic bronchitis and
half of those developed COPD.28 In the Seven Countries Study,
among continuous smokers without chronic bronchitis or any
other pulmonary disease, those with a smoking history of
20–40 pack-years (P=0.001) or .40 pack-years (P=0.002) had
lower mean FEV0.75 than those with a smoking history of ,20
pack-years.28 Furthermore, of smokers with no airflow obstruction in the COPDGene study, those with chronic bronchitis had
a greater pack-year smoking history and were more likely to
be current smokers than those without chronic bronchitis.29 In
that study, non-obstructive chronic bronchitis was defined by
a history of cough and phlegm production for $3 consecutive months per year, and its results suggest that bronchitic
symptoms such as productive cough in the absence of airflow
obstruction could be an early marker of susceptibility and
risk for COPD.29–31 Unfortunately, COPD in the current study
was defined by having emphysema, chronic bronchitis, and/or
COPD, so that those subgroups cannot be determined.
Little information has been available in US populations to
address the relationship between smoking duration, COPD,
and respiratory symptoms, so this study is unique. However, our study had several limitations. First, the BRFSS is
a cross-sectional study of the South Carolina population, so
causal relationships between smoking duration, COPD,
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and respiratory symptoms cannot be established. Second,
the study response rate was less than 50% and selection
bias might influence our results if participation varied by
smoking duration. Third, the analyses relied on self-reported
information from a telephone interview about current smoking, smoking duration, respiratory symptoms, and COPD,
and cannot be validated. However, previous studies support
that a self-report of provider-diagnosed COPD is highly
reliable,18,32 although undiagnosed COPD may affect our
results.33–35 Validity may also differ between self-reported
emphysema and self-reported chronic bronchitis.36
While 76.4% of subjects with self-reported COPD also
reported having had a breathing test in our study, there is no
information regarding test interpretation. However, having
had a breathing test did not differ by smoking status among
those with COPD. This finding is comparable with that of a
larger 2011 US survey of approximately 13,000 adults with
self-reported COPD, in which the percentage of subjects having had a breathing test to diagnose COPD did not differ by
smoking status.37 Furthermore, use of smoking duration and
current smoking status give only partial information about
tobacco use. Other useful information for such a study could
include intensity (number or packs smoked per day), pack-years
(a product of intensity and duration), age at initiation, and time
since cessation, but such information cannot be obtained during
a time-limited interview.19 However, our results are consistent
with findings for pack-years of smoking that have been applied
in previous studies.5–7 In addition, using smoking duration rather
than pack-years or additional smoking indicators that employ
a time factor in the same analytic models may have helped to
reduce multicollinearity and avoid a cohort effect.19
The US Preventive Services Task Force so far has found
no evidence to support screening adults (including asymptomatic smokers) for COPD using spirometry.38 However,
the recommendations do suggest that current smokers should
receive smoking cessation counseling and pharmacologic
therapies that have been demonstrated to increase cessation
rates. Smoking cessation may improve respiratory symptoms
and bronchial hyperresponsiveness and prevent excessive
decline in lung function among smokers with COPD as well
as among smokers without chronic symptoms.21 Smokers
with respiratory symptoms, including dyspnea and productive
cough, may be more susceptible to the effects of smoking
on rate of decline in FEV1 than those without symptoms,
thus representing an important target group for smoking
cessation interventions.14 The United States Public Health
Service guidelines recommend a simple intervention of “5
As”, ie, “ask about tobacco use”, “advise to quit”, “assess
willingness to make a cessation attempt”, “assist in cessation
International Journal of COPD 2015:10
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attempt”, and “arrange follow-up” to make prevention and
cessation of tobacco use more successful.39 Therefore, there
are opportunities for physicians to provide tobacco cessation counseling to all patients who smoke, particularly those
with respiratory symptoms and/or COPD. Such efforts will
have the largest impact on decreasing COPD in men and
women alike.

Conclusion
In this population-based survey of adults with a smoking history, prolonged tobacco use was associated with an increased
likelihood of having COPD, frequent productive cough,
frequent SOB, and agreement that SOB affected physical
activity even after controlling for current smoking behavior.
Former smokers who had quit smoking for $10 years had a
lower prevalence of COPD and respiratory symptoms than
current smokers. The prevalence of COPD was higher in
women than in men at all levels of smoking duration. This
study also demonstrates that the BRFSS is a useful surveillance tool to describe the association of potential risk factors
for COPD and respiratory symptoms in an adult state population and could be expanded to other US states for public
health surveillance purposes.
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